Clinical Trials Logo

Filter by:
NCT ID: NCT05936255 Terminated - Suicidal Ideation Clinical Trials

Pilot Examination of a Telehealth, Cognitive-behavioral Therapy for Adolescents

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

This project is designed to refine a 6-week telehealth therapy intervention targeting negative interpersonal beliefs among community-dwelling youth with elevated levels of psychopathology. The study design is a single-arm open trial. The intervention is comprised of weekly teen and parent group cognitive-behavioral therapy, regular check-ins with the youths, and a module embedded throughout treatment that targets negative interpersonal beliefs (i.e., perceived social disconnection, burdensomeness). The goal of the study is to evaluate the feasibility of the treatment and assessment protocol, refine the intervention based on qualitative feedback, and evaluate changes in negative interpersonal beliefs. Youths complete two qualitative interviews about their interpersonal relationships and their feedback about the intervention.

NCT ID: NCT05915910 Terminated - Clinical trials for Glycogen Storage Disease Type IB

Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)

Start date: April 27, 2023
Phase:
Study type: Observational

The primary objective of this study is to collect whole blood from patients diagnosed with Glycogen storage disease type 1B, which will be used to support the investigation of potential therapies that address the genetic basis of this disease.

NCT ID: NCT05915897 Terminated - Clinical trials for Chronic Granulomatous Disease

Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

Start date: May 23, 2023
Phase:
Study type: Observational

The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Chronic Granulomatous Disease (CGD). The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.

NCT ID: NCT05910853 Terminated - Fanconi Anemia Clinical Trials

Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia

Start date: May 24, 2023
Phase:
Study type: Observational

The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Fanconi Anemia. The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.

NCT ID: NCT05910697 Terminated - Prostate Cancer Clinical Trials

Clinical Utility of MyProstateScore 2.0 P2

Start date: March 31, 2023
Phase: N/A
Study type: Interventional

This is an extension of an ongoing study. Preliminary results from the ongoing study indicate that the MyProstateScore 2.0 (MPS 2.0) Test is significantly improving early diagnosis of prostate cancer. This extension will allow us to ask the study participants in the ongoing study to share patient-level data for chart abstraction. The specific purpose of this study is to generate high-quality real-world data on the clinical utility of LynxDx's new MPS 2.0 test.

NCT ID: NCT05888337 Terminated - Myopia Clinical Trials

Comparison of Contoura Vision Outcomes Programmed Using the Manifest Refraction Verses Using Phorcides Planning Software in Patients With Oblique Astigmatism

Start date: June 20, 2023
Phase:
Study type: Observational

The objective is to compare the percentage of monocular UDVA -0.1 logMAR (20/16) outcomes for each planning strategy (Phorcides and manifest refraction) at the 3-month post operative visit.

NCT ID: NCT05878652 Terminated - ACL Injury Clinical Trials

Playmaker 3D Printed Knee Extender

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the development of, and patient outcomes associated with, the use of individually printed knee extender in conjunction with a video-based home pre-habilitation program for patients who have suffered an ACL rupture before surgery.

NCT ID: NCT05877404 Terminated - Endometrial Cancer Clinical Trials

Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer

Start date: August 15, 2023
Phase:
Study type: Observational

In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic oncologists who belong to the society of gynecologic oncology, via an email survey, to better understand current practices surrounding tumor genetic testing as well as determine if there have been any changes to practice since the publication of recent trials on the use of immune-checkpoint inhibitors in endometrial cancer.

NCT ID: NCT05877066 Terminated - Clinical trials for Dupuytren's Contracture

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

GRASP-DC
Start date: June 14, 2023
Phase:
Study type: Observational [Patient Registry]

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.

NCT ID: NCT05873595 Terminated - Peyronie's Disease Clinical Trials

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease

CURVE-PD
Start date: June 20, 2023
Phase:
Study type: Observational [Patient Registry]

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.